5Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization [J]. Int J Biochem Cell Biol,2004,36(4) :568-584.
6Fang B, Shi M, Liao L, et al. Multiorgan engraftment and multilineage differentiation by human fetal bone marrow Flkl +/ CD31 -/CD34- progenitors [J]. 2003,12(6) :603-613.
7Fang B, Liao L, Shi M, et al. Multipotency of FlklCD34 progenitors derived from human fetal bone marrow [ J ]. J Lab Clin Med, 2004,143 (4) :230-240.
8Dormady SP, Bashayan O, Dougherty B, et al. Immortalized multipotcntial mesenchymal cells and the hematopoietic microenviranment [ J ]. J Hematother Stem Cell Res, 2001,10 ( 1 ) : 125-140.
9Tse WT, Pendleton JD, Beycr WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation [ J ]. Transplantation, 2003,75 ( 3 ) : 389 - 397.
10Lee ST, Jang JH, Cheong J-W, et al. Treatment ot high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded manrrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype [J]. Br J Haematol, 2002,118(4) :1128-1131.
